📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
96 announcements match the current filters (relevance ≥ 5).
Meghmani Organics to Hold Meetings on June 6 for Merger of Two Subsidiaries
Meghmani Organics Limited (MOL) has received an NCLT order to convene meetings on June 06, 2026, to approve the Scheme of Amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition with itself. The consolidation aims to streamline the corporate structure and integrate the crop nutrition business directly under the listed parent entity. Meetings for equity shareholders, secured creditors, and unsecured creditors will be conducted via video conferencing. This is a significant regulatory step toward completing the merger process initiated under the Companies Act, 2013.
Key Highlights
NCLT Ahmedabad Bench directed convening of stakeholder meetings via order dated April 30, 2026.
Equity shareholders of Meghmani Organics will meet on June 06, 2026, at 2:00 PM IST.
The merger involves two entities: Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited.
Separate meetings for secured and unsecured creditors of all three companies are scheduled between 10:00 AM and 3:00 PM on June 06.
The amalgamation is being processed under Sections 230 to 232 of the Companies Act, 2013.
👀 What to Watch
Investors should review the upcoming detailed notice and explanatory statement to understand the swap ratios and synergy benefits. Participation in the June 6 meeting is advised to vote on the proposed consolidation.
CRISIL Reaffirms Meghmani Organics Rating at 'A', Revises Outlook to 'Negative'
CRISIL Ratings has reaffirmed the long-term rating of Meghmani Organics Limited at 'CRISIL A' but has revised the outlook from 'Stable' to 'Negative'. The short-term rating remains reaffirmed at 'CRISIL A1' for bank facilities totaling Rs. 1,094 crore. A 'Negative' outlook indicates that the rating may be downgraded in the future if the company's financial or operational performance remains under pressure. This review covers a wide range of fund-based and non-fund-based facilities across multiple major banks.
Key Highlights
CRISIL reaffirmed the long-term rating at 'CRISIL A' but revised the outlook to 'Negative' from 'Stable'.
Short-term rating reaffirmed at 'CRISIL A1' for total bank facilities of Rs. 1,094 crore.
The rating covers 19 specific bank facility classes, including a Rs. 250 crore cash credit from State Bank of India.
Major exposures include ICICI Bank (Rs. 115 crore) and HDFC Bank (Rs. 95 crore) across various limits.
The outlook revision suggests potential concerns regarding the company's credit profile or debt-servicing ability in the medium term.
👀 What to Watch
Investors should exercise caution as the 'Negative' outlook suggests a potential credit downgrade if financial metrics do not improve. Monitor the company's debt levels and interest coverage ratios in upcoming quarterly reports.
Mold-Tek Technologies Withdraws April 24 Record Date; Interim Dividend Declaration Deferred
Mold-Tek Technologies has officially withdrawn the record date of April 24, 2026, which was previously established for a proposed interim dividend. This decision follows a Board of Directors meeting on April 20, 2026, where the board opted to defer the declaration of the interim dividend for the financial year 2025-26. Consequently, the anticipated immediate cash return to shareholders is postponed. Investors will need to wait for a future board meeting to reconsider the dividend payout.
Key Highlights
Withdrawal of the previously announced record date of April 24, 2026.
Board of Directors deferred the interim dividend declaration for FY 2025-26 during the April 20 meeting.
The move follows a prior communication dated April 15, 2026, which had originally set the dividend timeline.
No new date for the consideration of the interim dividend has been provided in the current update.
👀 What to Watch
Investors should monitor upcoming exchange filings for a rescheduled board meeting date to understand the reasons for the deferral and the revised dividend timeline.
Mold-Tek Packaging Declares First Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has announced its first interim dividend for the financial year 2025-26. The Board of Directors approved a payout of ₹2 per equity share, which translates to 40% of the face value of ₹5. The record date to determine shareholder eligibility has been set for April 24, 2026. This announcement demonstrates the company's consistent policy of rewarding shareholders through periodic payouts.
Key Highlights
First Interim Dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for dividend eligibility is fixed as April 24, 2026
The dividend will be paid within the stipulated legal timelines
👀 What to Watch
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date (typically one day prior to the record date). The payout reflects healthy cash flows and a shareholder-friendly management approach.
Mold-Tek Packaging Declares Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has declared its first interim dividend of ₹2 per equity share for the financial year 2025-26. This dividend represents a 40% payout on the face value of ₹5 per share. The company has established April 24, 2026, as the record date to identify eligible shareholders for this payment. The board meeting was conducted efficiently, concluding within 35 minutes on April 20, 2026.
Key Highlights
Interim dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for eligibility fixed as Friday, April 24, 2026
Board meeting held on April 20, 2026, between 11:00 A.M. and 11:35 A.M.
👀 What to Watch
Investors interested in the dividend should ensure they hold the stock before the ex-dividend date to be eligible for the ₹2 per share payout. This announcement reflects the company's commitment to returning value to shareholders.
Meghmani Organics Re-appoints 3 Independent Directors for 3-Year Terms
Meghmani Organics Limited (MOL) has received shareholder approval to re-appoint three Independent Directors for a second term of three years, effective May 5, 2026. The appointees include Mr. Manubhai Patel, a finance expert with 45+ years of experience, Prof. (Dr) Ganapati Yadav, a Padma Shri recipient and chemical engineering scientist, and Ms. Urvashi Shah, a legal expert with 21 years of practice. These re-appointments ensure continuity in the board's oversight and strategic guidance until May 4, 2029. The retention of such high-caliber professionals in finance, green chemistry, and law strengthens the company's governance and sustainability framework.
Key Highlights
Re-appointment of 3 Independent Directors for a second term of 3 consecutive years starting May 5, 2026
Mr. Manubhai Patel brings over 45 years of financial management experience, including a tenure as CFO of Zydus Group
Prof. (Dr) Ganapati Yadav, a Padma Shri awardee, contributes expertise with over 570 publications and 140 patents in chemical engineering
Ms. Urvashi Shah provides 21 years of legal expertise in taxation and regulatory compliance
The re-appointments were approved by shareholders via Special Resolutions in accordance with SEBI regulations
👀 What to Watch
Investors should view this as a positive sign of board stability and strong corporate governance. No immediate action is required as these are planned re-appointments of highly qualified professionals.
Mold-Tek Technologies Board to Meet April 20 for Interim Dividend; Record Date April 24
Mold-Tek Technologies has scheduled a board meeting on April 20, 2026, to consider the declaration of the first interim dividend for the financial year 2025-26. The company has pre-emptively fixed April 24, 2026, as the record date to determine shareholder eligibility, contingent on board approval. Furthermore, the trading window for insiders remains closed from April 1, 2026, until 48 hours after the announcement of audited FY26 results. This move indicates a proactive approach to shareholder returns early in the new fiscal year.
Key Highlights
Board meeting scheduled for April 20, 2026, to consider First Interim Dividend for FY 2025-26.
Record date for dividend eligibility fixed as April 24, 2026, subject to board approval.
Trading window remains closed from April 1, 2026, until 48 hours after audited FY26 results are declared.
The announcement follows the conclusion of the financial year ended March 31, 2026.
👀 What to Watch
Investors should monitor the outcome of the April 20 meeting for the dividend amount. To be eligible for the payout, shares must be purchased before the ex-dividend date, which is typically one working day prior to the April 24 record date.
Mold-Tek Packaging Board to Consider Interim Dividend on April 20; Record Date April 24
Mold-Tek Packaging Limited has scheduled a board meeting on April 20, 2026, to consider and declare the first interim dividend for the financial year 2025-26. The company has proactively fixed April 24, 2026, as the record date to determine shareholder eligibility for the potential payout. This announcement comes while the trading window remains closed since April 1, 2026, in anticipation of the audited financial results for the year ended March 31, 2026. Investors should watch for the specific dividend amount to be disclosed following the board's decision.
Key Highlights
Board meeting scheduled for April 20, 2026, to deliberate on the first interim dividend for FY 2025-26.
Record date for dividend eligibility is fixed as Friday, April 24, 2026, contingent on board approval.
Trading window for designated persons has been closed since April 1, 2026, pending audited annual results.
The move signals management's intent to return capital to shareholders early in the new fiscal year.
👀 What to Watch
Investors seeking dividend income should monitor the April 20 announcement for the quantum of the dividend. To be eligible for the payout, shares must be held in the demat account by the record date of April 24, 2026.
Mold-Tek Technologies to Use Rs 4.76 Cr Preferential Issue Proceeds for Nashik Office Construction
Mold-Tek Technologies Limited has clarified the utilization of Rs 4.756 crore raised through a preferential issue of equity shares. The company intends to deploy 100% of these funds toward capital expenditure for a new branch office in Nashik, Maharashtra. This move will transition the Nashik operations from rented premises to a company-owned facility on land acquired in 2023. The project is expected to be completed within 15 to 18 months, supporting long-term business growth and operational stability.
Key Highlights
Total proceeds from the preferential issue aggregate to Rs 4,75,60,000
100% of the funds are allocated for capital expenditure on a new Nashik branch office
The project aims to replace current rented premises with a dedicated facility on land owned since 2023
Estimated timeline for completion is 15 to 18 months from the date of share allotment
👀 What to Watch
Investors should view this as a positive step toward asset creation and operational efficiency. Monitor the execution timeline of 15-18 months to ensure the expansion stays on track.
Meghmani Organics Subsidiary Kilburn Chemicals Rating Outlook Revised to Positive for ₹274 Cr Debt
India Ratings & Research has revised the credit rating outlook for Kilburn Chemicals Limited (KCL), a subsidiary of Meghmani Organics, from 'Negative' to 'Positive' implications. The revision affects bank loan facilities totaling ₹274.2 crore, including a ₹199.2 crore term loan and ₹75 crore in working capital limits. The subsidiary's long-term rating is currently IND BBB, while the short-term rating is IND A3+. This change suggests an improving financial trajectory for the subsidiary, which could eventually lead to lower borrowing costs for the group.
Key Highlights
Rating watch for subsidiary Kilburn Chemicals revised from 'Negative Implications' to 'Positive Implications'.
Total rated bank facilities amount to ₹2,742 million (₹274.2 crore).
Long-term rating maintained at IND BBB and short-term rating at IND A3+.
The facilities include a ₹199.2 crore term loan and a ₹75 crore working capital limit from HDFC Bank.
👀 What to Watch
This indicates improving creditworthiness of a key subsidiary; investors should monitor for a formal rating upgrade which could signal better operational performance and reduced consolidated interest costs.
Mold-Tek Technologies Shareholders Approve Preferential Equity Issue with 100% Majority
Mold-Tek Technologies Limited has received near-unanimous shareholder approval for the issuance of equity shares on a preferential basis during its Extraordinary General Meeting held on March 30, 2026. The special resolution was passed with 15,371,048 votes in favor, representing approximately 100% of the valid votes cast. This approval allows the company to proceed with its capital-raising plans through the targeted issuance of new equity. The strong mandate from shareholders indicates significant support for the company's strategic financial objectives.
Key Highlights
Special Resolution for the issue of equity shares on a preferential basis was passed with requisite majority.
A total of 15,371,048 votes (100% of valid votes) were cast in favor of the resolution.
Only 2 votes from a single member were recorded against the proposal.
100 members participated in the voting process via remote e-voting and electronic voting at the EGM.
The voting results were verified by Scrutinizer Ashish Kumar Gaggar and submitted to the exchanges on April 1, 2026.
👀 What to Watch
Investors should monitor subsequent filings for details on the issue price and the specific entities receiving the shares to evaluate potential dilution and strategic benefits. The overwhelming shareholder support is a positive sign of confidence in the management's growth plans.
Mold-Tek Technologies Approves Preferential Issue of Equity Shares at EGM
Mold-Tek Technologies Limited held an Extraordinary General Meeting (EGM) on March 30, 2026, to seek shareholder approval for a preferential issue of equity shares. The meeting, attended by 56 members, focused on this special resolution aimed at raising capital for the company. While specific pricing and allotment details were not disclosed in this summary, the Chairman provided an overview of the strategic intent behind the issue. The final approval depends on the voting results, which will be disclosed separately.
Key Highlights
Special Resolution proposed for the issuance of equity shares on a preferential basis.
The EGM was attended by 56 members via video conferencing on March 30, 2026.
Remote e-voting was conducted between March 26 and March 29, 2026, with a cut-off date of March 23, 2026.
The meeting concluded in 36 minutes after addressing shareholder queries regarding the fundraise.
👀 What to Watch
Investors should monitor the upcoming disclosure of voting results and specific details regarding the issue price and allottees. This capital infusion is a key indicator of the company's growth or deleveraging plans.
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue to US-based Investor
Mold-Tek Technologies Limited has called for an Extraordinary General Meeting (EGM) on March 30, 2026, to approve a preferential issue of equity shares. The company intends to issue 2,90,000 equity shares at a price of ₹164 per share to Mr. Richard Leon Cannyn, a non-promoter individual. This transaction will result in a capital infusion of approximately ₹4.76 Crores. The issue price represents a face value of ₹2 and a premium of ₹162 per share.
Key Highlights
Preferential allotment of 2,90,000 equity shares to a non-promoter individual investor.
Total fundraise amount is approximately ₹4.756 Crores at an issue price of ₹164 per share.
Relevant date for price determination was set as February 27, 2026.
EGM scheduled for March 30, 2026, with remote e-voting available from March 26 to March 29, 2026.
The shares issued will be subject to a statutory lock-in period as per SEBI ICDR Regulations.
👀 What to Watch
Investors should note the entry of a foreign individual investor and monitor the company's disclosure regarding the specific use of these funds for growth or debt reduction. The equity dilution from this specific issue is relatively small but indicates management's intent to bring in external capital.
Mold-Tek Technologies to Raise Rs 4.76 Crore via Preferential Issue at Rs 164/Share
Mold-Tek Technologies has approved the issuance of 2,90,000 equity shares on a preferential basis to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at Rs 164 each, representing a significant premium over the face value of Rs 2. The total fundraise amounts to approximately Rs 4.76 crore, which will result in the investor holding a 0.997% stake in the company post-allotment. An Extraordinary General Meeting (EGM) is scheduled for March 30, 2026, to seek shareholder approval for the transaction.
Key Highlights
Issuance of up to 2,90,000 equity shares at an issue price of Rs 164 per share.
Total fundraise amount aggregates to Rs 4,75,60,000 from a single non-promoter investor.
The investor, Richard Leon Cannyn, will hold a 0.997% stake in the company post-issue.
Relevant date for pricing as per SEBI ICDR Regulations is February 27, 2026.
Extraordinary General Meeting (EGM) to be held on March 30, 2026, for shareholder approval.
👀 What to Watch
Investors should note the equity dilution of approximately 1% and monitor how the company intends to utilize these funds for growth. The preferential pricing provides a benchmark for the company's current valuation assessment by external investors.
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue at ₹164 Per Share
Mold-Tek Technologies has approved a preferential allotment of 2,90,000 equity shares to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at ₹164 each, which includes a premium of ₹162, totaling a fundraise of approximately ₹4.76 crore. This issuance will result in the investor holding a 0.997% stake in the company post-allotment. Shareholders will vote on this proposal at an Extraordinary General Meeting (EGM) scheduled for March 30, 2026.
Key Highlights
Issuance of up to 2,90,000 equity shares at a price of ₹164 per share.
Total capital infusion of ₹4,75,60,000 from a single non-promoter investor.
Post-issue, the investor Mr. Richard Leon Cannyn will hold a 0.997% stake in the company.
Extraordinary General Meeting (EGM) convened for March 30, 2026, to seek shareholder approval.
Relevant date for determining the floor price was set as February 27, 2026.
👀 What to Watch
The fundraise is relatively small but positive as it brings in fresh capital at a premium to face value. Investors should monitor the EGM outcome and the company's plans for utilizing these funds for growth.
Mold-Tek Technologies to Raise Rs 4.76 Crore via Preferential Issue at Rs 164/Share
Mold-Tek Technologies has approved the issuance of 2,90,000 equity shares on a preferential basis to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at Rs 164 each, representing a significant premium over the face value of Rs 2. The total fundraise amounts to approximately Rs 4.76 crore, with the investor set to hold a 0.997% stake post-allotment. An Extraordinary General Meeting is scheduled for March 30, 2026, to obtain shareholder approval for this transaction.
Key Highlights
Issuance of 2,90,000 equity shares at a fixed price of Rs 164 per share
Total capital infusion of approximately Rs 4.76 crore from a non-promoter investor
Post-allotment, the identified investor will hold a 0.997% stake in the company
Extraordinary General Meeting (EGM) scheduled for March 30, 2026, for approval
Relevant date for pricing determination set as February 27, 2026
👀 What to Watch
Investors should view this as a minor positive due to the capital infusion at a premium, though the dilution is minimal at less than 1%. Monitor the EGM outcome and any further disclosures regarding the specific use of these funds for business expansion.
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue at ₹164 per Share
Mold-Tek Technologies' board has approved a preferential allotment of 2,90,000 equity shares to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at ₹164 each, including a premium of ₹162, aggregating to a total fundraise of approximately ₹4.76 crores. This issuance will result in the investor holding a 0.997% stake in the company post-allotment. An Extraordinary General Meeting (EGM) is scheduled for March 30, 2026, to seek shareholder approval for this capital infusion.
Key Highlights
Board approved issuance of 2,90,000 equity shares at a price of ₹164 per share
Total capital to be raised through this preferential allotment is ₹4,75,60,000
The shares are being allotted to a single non-promoter investor, Mr. Richard Leon Cannyn
Post-allotment, the investor will hold a 0.997% stake in the company
Extraordinary General Meeting (EGM) for shareholder approval is set for March 30, 2026
👀 What to Watch
The fundraise is relatively small in scale but indicates external investor interest; shareholders should monitor the company's plans for utilizing this capital. No immediate action is required as the dilution is minimal at less than 1%.
Meghmani Organics Subsidiary Kilburn Chemicals Assigned IND BBB Rating with Negative Watch
India Ratings & Research has assigned credit ratings to Kilburn Chemicals Limited, a subsidiary of Meghmani Organics Limited. The ratings cover bank facilities totaling INR 2,742 million, including a term loan of INR 1,992 million and working capital limits of INR 750 million. Notably, all rated facilities have been placed on 'Rating Watch with Negative Implications,' signaling potential downward pressure on the credit profile. Investors should monitor the subsidiary's operational performance as it may impact the parent company's consolidated financial health.
Key Highlights
India Ratings assigned 'IND BBB' rating to Kilburn Chemicals' INR 1,992 million term loan.
Working capital limits of INR 750 million received 'IND BBB' and 'IND A3+' ratings.
Total rated bank facilities for the subsidiary amount to INR 2,742 million.
All facilities are placed on 'Rating Watch with Negative Implications' as of February 27, 2026.
👀 What to Watch
Investors should monitor the reasons behind the 'Negative Implications' watch, as a potential downgrade could increase borrowing costs for the subsidiary and affect the parent company's valuation.
Mold-Tek Technologies Q3 Profits Surge 6x YoY; Targets $25M Revenue in FY27
Mold-Tek Technologies reported a stellar Q3 FY26 with profits growing over sixfold year-on-year and 20.2% sequentially. The company is aggressively restructuring its underperforming automotive division, reducing headcount from 160 to 60 to focus on high-growth areas like transmission poles and data centers. Management has set a revenue target of $25 million (approx. INR 225-230 crores) for next year, driven by the integration of the Beryl acquisition and offshoring benefits. The company aims for a 20-25% CAGR over the next 3-5 years through organic growth and further strategic acquisitions.
Key Highlights
Q3 FY26 profits increased by more than 6x YoY and 20.2% on a QoQ basis.
Revenue guidance for FY27 set at $25 million, representing a significant jump from the estimated INR 180 crores in FY26.
Beryl acquisition contributed $137,000 (INR 1.25 crores) in operating profit during its first two months of operations.
Mechanical Engineering (MES) division is being downsized from 160 to 60 members to eliminate losses and improve efficiency.
Data center projects are expected to contribute $2.5 million to $3.5 million in incremental annual revenue across civil and mechanical segments.
👀 What to Watch
Investors should view the aggressive cost-cutting in the automotive segment and the successful integration of Beryl as strong catalysts for margin expansion. Monitor the company's ability to transition Beryl's high-cost US operations to its Indian back-office to realize projected profitability gains.
Mold-Tek Packaging Q3 FY26: EBITDA Up 14%, Targets ₹1,000 Cr Revenue in FY27
Mold-Tek Packaging reported a 14% YoY EBITDA growth in Q3 FY26, despite the quarter being seasonally weak. The company is consolidating its Hyderabad operations from five units into two to enhance operational efficiency and cost control, with benefits expected from next quarter. Management has set an ambitious revenue target of over ₹1,000 crore for FY27, driven by a 12-15% volume growth outlook. The Pharma segment remains a key growth lever, with a target of ₹50-55 crore for the next fiscal year.
Key Highlights
9M FY26 EBITDA grew by 20% YoY, while Q3 volumes increased by 6%.
Revised FY26 volume guidance to 42,500 tons (11% growth) due to extended monsoons.
Pharma segment on track for ₹35 crore in FY26 with 25+ clients cleared for production.
Manufacturing consolidation in Hyderabad to be completed by March 2026 to improve margins.
Projected FY26 PAT of ₹73-75 crore, representing a 20% year-on-year growth.
👀 What to Watch
Investors should focus on the company's transition into high-margin Pharma packaging and the efficiency gains from plant consolidation. The ₹1,000 crore revenue guidance for FY27 suggests strong management confidence in volume recovery.
